Duration of intrapartum antibiotics for group B streptococcus on the diagnosis of clinical neonatal sepsis

Infectious Diseases in Obstetrics and Gynecology

Volumn 2013, Issue , 2013, Pages

  Turrentine, Mark A ^a   Greisinger, Anthony J ^b   Brown, Kimberly S ^b   Wehmanen, Oscar A ^b   Mouzoon, Melanie E ^c  

^a Kelsey Seybold Clinics   (United States)

^b Kelsey Research Foundation   (United States)

^c Kelsey Seybold Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL COLONIZATION; FETUS; FETUS OUTCOME; GESTATIONAL AGE; GROUP B STREPTOCOCCAL INFECTION; HUMAN; INCIDENCE; INFECTION RISK; INTRAPARTUM CARE; LABOR; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SEPSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STREPTOCOCCUS AGALACTIAE; TREATMENT DURATION; DISEASE TRANSMISSION; FEMALE; HETEROZYGOTE; MALE; METHODOLOGY; MICROBIOLOGY; MULTIVARIATE ANALYSIS; PREGNANCY; SEPSIS; STREPTOCOCCUS INFECTION; TIME; UNITED STATES; VERTICAL TRANSMISSION;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CARRIER STATE; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MULTIVARIATE ANALYSIS; PREGNANCY; RETROSPECTIVE STUDIES; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TEXAS; TIME FACTORS;

EID: 84876564328     PISSN: 10647449     EISSN: 10980997     Source Type: Journal    
DOI: 10.1155/2013/525878     Document Type: Article

References (21)

1. Centers for Disease Control Prevention, Prevention of perinatal group B streptococcal disease: a public health perspective. Morbidity and Mortality Weekly Report 1996 45 RR-7 1 24
2. Centers for Disease Control Prevention, Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. Morbidity and Mortality Weekly Report 2002 51 RR-11 1 22 2-s2.0-0037118991
3. Centers for Disease Control Prevention, Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. Morbidity and Mortality Weekly Report 2010 59 RR-10 1 22 2-s2.0-0037118991
4. Boyer K. M., Gadzala C. A., Kelly P. D., Gotoff S. P., Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission. Journal of Infectious Diseases 1983 148 5 810 816 2-s2.0-0021036184 (Pubitemid 14244266)
5. Pylipow M., Gaddis M., Kinney J. S., Selective intrapartum prophylaxis for group B Streptococcus colonization: management and outcome of newborns. Pediatrics 1994 93 4 631 635 2-s2.0-0028215653 (Pubitemid 24106611)
6. Lin F. Y. C., Brenner R. A., Johnson Y. R., Azimi P. H., Philips J. B., Regan J. A., Clark P., Weisman L. E., Rhoads G. G., Kong F., Clemens J. D., The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. The American Journal of Obstetrics and Gynecology 2001 184 6 1204 1210 2-s2.0-0035340489 10.1067/mob.2001.113875 (Pubitemid 32434274)
7. de Cueto M., Sanchez M. J., Sampedro A., Miranda J. A., Herruzo A. J., Rosa-Fraile M., Timing of intrapartum ampicillin and prevention of vertical transmission of group B Streptococcus. Obstetrics and Gynecology 1998 91 1 112 114 2-s2.0-0031983469 10.1016/S0029-7844(97)00587-5 (Pubitemid 28042344)
8. Lijoi D., Capua E. D., Ferrero S., Mistrangelo E., Giannattasio A., Morano S., Ragni N., The efficacy of 2002 CDC guidelines in preventing perinatal group B Streptococcal vertical transmission: a prospective study. Archives of Gynecology and Obstetrics 2007 275 5 373 379 2-s2.0-33947528520 10.1007/s00404-006-0263-7 (Pubitemid 46466372)
9. Berardi A., Rossi C., Biasini A., Minniti S., Venturelli C., Ferrari F., Facchinetti F., Efficacy of intrapartum chemoprophylaxis less than 4 hours duration. Journal of Maternal-Fetal and Neonatal Medicine 2011 24 4 619 625 2-s2.0-79952430469 10.3109/14767058.2010.511347
10. Illuzzi J. L., Bracken M. B., Duration of intrapartum prophylaxis for neonatal group B streptococcal disease: a systematic review. Obstetrics and Gynecology 2006 108 5 1254 1265 2-s2.0-33750501146 10.1097/01.AOG.0000241539. 86451.11 (Pubitemid 44665425)
11. International Classification of Diseases 9th revision, Clinical Modification 2008 6th Salt Lake City, Utah, USA St. Anthony Publishing (Ingenix)
12. Ottolini M. C., Lundgren K., Mirkinson L. J., Cason S., Ottolini M. G., Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn. Pediatric Infectious Disease Journal 2003 22 5 430 434 2-s2.0-0037910174 10.1097/00006454-200305000-00008 (Pubitemid 36578745)
13. Bromberger P., Lawrence J. M., Braun D., Saunders B., Contreras R., Petitti D. B., The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants. Pediatrics 2000 106 2 I 244 250 2-s2.0-0033885813 (Pubitemid 30639057)
14. Escobar G. J., Li D. K., Armstrong M. A., Gardner M. N., Folck B. F., Verdi J. E., Xiong B., Bergen R., Neonatal sepsis workups in infants ≥2000 grams at birth: a population-based study. Pediatrics 2000 106 2 I 256 263 2-s2.0-0033869654 (Pubitemid 30636392)
15. Goins W. P., Talbot T. R., Schaffner W., Edwards K. M., Craig A. S., Schrag S. J., Van Dyke M. K., Griffin M. R., Adherence to perinatal group B streptococcal prevention guidelines. Obstetrics and Gynecology 2010 115 6 1217 1224 2-s2.0-77953016899 10.1097/AOG.0b013e3181dd916f
16. Schrag S. J., Zell E. R., Lynfield R., Roome A., Arnold K. E., Craig A. S., Harrison L. H., Reingold A., Stefonek K., Smith G., Gamble M., Schuchat A., A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. The New England Journal of Medicine 2002 347 4 233 239 2-s2.0-0037173458 10.1056/NEJMoa020205 (Pubitemid 34787629)
17. de Cueto M., Sanchez M. J., Molto L., Miranda J. A., Herruzo A. J., Ruiz-Bravo A., De la Rosa-Fraile M., Efficacy of a universal screening program for the prevention of neonatal group B streptococcal disease. The European Journal of Clinical Microbiology and Infectious Diseases 1995 14 9 810 812 2-s2.0-0028790007 10.1007/BF01690999
18. Bloom S. L., Cox S. M., Bawdon R. E., Gilstrap L. C., Ampicillin for neonatal group B streptococcal prophylaxis: how rapidly can bactericidal concentrations be achieved? The American Journal of Obstetrics and Gynecology 1996 175 4 I 974 976 2-s2.0-0029957257 10.1016/S0002-9378(96)80035-4 (Pubitemid 26357965)
19. Colombo D. F., Lew J. L., Pedersen C. A., Johnson J. R., Fan-Havard P., Optimal timing of ampicillin administration to pregnant women for establishing bactericidal levels in the prophylaxis of group B Streptococcus. The American Journal of Obstetrics and Gynecology 2006 194 2 466 470 2-s2.0-31744452321 10.1016/j.ajog.2005.07.098 (Pubitemid 43183702)
20. Barber E. L., Zhao G., Buhimschi I. A., Illuzzi J. L., Duration of intrapartum prophylaxis and concentration of penicillin G in fetal serum at delivery. Obstetrics and Gynecology 2008 112 2 265 270 2-s2.0-51649098577 10.1097/AOG.0b013e31817d0246
21. Grimes D. A., False alarms and pseudo-epidemics. The limitations of observational epidemiology. Obstetrics and Gynecology 2012 120 4 920 927